2Yamada K,Furusawa S,Saito K,et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aelarubiein for previously treated acute myelogenous leukemia:a pilot study[J]. Leukemia, 1995,9(1), 10-14.
3Saito K,Nakamura Y,Aoyagi M,et al. Low-dose eytarabine and aelarubiein in combination with granuloeyte colony stimulating faetor(CAG) regimen for previously treated patients with relapsed or primary resistant acute myelogenously leukemia(AML) and previously untreated elderly patients with AML, secondaryAML,and refractory anemia with excess blasts in transformation[J], Int J Hematol,2000,71(3):238-244.
4Park LS,Waldron PE,Friend D,et ah lnterleukin-3,GM-CSF and G-CSF receptor expressiosn on cell lines and primary leukemiacell: receptor heterogeneity and relationship to growth factor responsiveness[J]. Blood, 1989,74(1) :56-65.
5Wormann B, Reuter C, Zuhlsdorf M,et al. Experimental basis forthe use of recombinant human granulocyte-maerophage colonystimulating factor in patients with acute myeloid leukemia [J].Semln Oncol, 1994,21 (6 Suppl 16):39-43.
